Supplementary Figure S1 from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

Figure 1A: Change in sum TLG after 1 dose of anti-EGFR therapy versus PFS. Green dots indicate patients with and red dots patients without treatment benefit after CT evaluation part 1. Grey line at data driven cut-off of < -15% change in sumTLG Figure 1B ROC curve of change in sum TLG and treatment benefit part 1 (AUC 0.89) Figure 1C: Kaplan-Meier survival curve for PFS for metabolic non-responders (